NOVARTIS PHARMACEUTICALS CORPORATION
Novartis Patient Assistance Foundation, Inc.
Information last checked August 27, 2026
Contact info
- Phone
- 1-800-277-2254
- Fax
- 1-844-730-2181
Eligibility
- Patient must be a US resident.
- Patient must meet program income requirements which may vary by product and household size.
- Patient must have limited or no private or public prescription coverage.
- Income limit, single
- Not published
- Income limit, couple
- Not published
- Medical expenses can be deducted
- Not published
- Social Security number asked for
- Yes
- US citizenship or residency required
- Yes
Not sure where your income falls? See this year's federal poverty guidelines (opens in a new tab).
Application process
- Documents to attach
- Proof of income
- Prescriber license number
- NPI number
- Both DEA and state license numbers
- Who can sign
- Physician
- Application can be faxed
- Yes
- Decision letter sent to
- Provider
Getting the medication
- Patient receives
- Medication
- Shipped to
- Patient. Note: For Clozaril, Focalin XR and Ritalin LA the patient will receive a pharmacy card.
- Supply per shipment
- Not published
- Time to first delivery
- 0–2 weeks
- Refills
- Contact program for refills
- Staying enrolled
- New application every 12 months
More from the program
Additional products may be available. Please contact the program for a complete product listing. www.pap.novartis.com
Medications covered
- Adakveo (crizanlizumab-tmca)
- Afinitor Disperz (everolimus)
- Beovu (brolucizumab-dbll)
- Coartem (artmether and lumefantrine tablets)
- Cosentyx (secukinumab)
- Fabhalta (iptacopan)
- Gilenya (fingolimod)
- Ilaris (canakinumab)
- Jadenu Sprinkle granules (deferasirox)
- Kesimpta injection (ofatumumab)
- Kisqali (ribociclib)
- Kisqali Femara Co-Pack tablets (ribociclib and letrozole)
- Leqvio (inclisiran injection)
- Lutathera (lutetium Lu 177 dotatate)
- Mayzent (siponimod)
- Mekinist (trametinib)
- Piqray (alpelisib)
- Pluvicto (lutetium LU 177 vipivotide tetraxetan injection)
- Promacta (eltrombopag)
- Rhapsido (remibrutinib)
- Rydapt (midostaurin capsule)
- Sandostatin LAR Depot (octreotide acetate)
- Scemblix tablet (asciminib tablet)
- Tabrecta (capmatinib)
- Tafinlar (dabrafenib)
- Tykerb (lapatinib tablets)
- Vanrafia (atrasentan)
- Vijoice (alpelisib)
- Votrient (pazopanib)
- Zykadia (ceritinib)